Insider · CIK 0001668163

Kim Mina

Reports to the SEC for 4 companies · AGOURA HILLS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001668163

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-21	ACELYRIN, Inc.A Award	Director, Chief Executive Officer	AAward	+89.5K sh	—	—	770,833
2025-05-21	ACELYRIN, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−363K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−85.2K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−190K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.2M sh	—	—	0
2025-05-21	ACELYRIN, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−771K sh	—	—	0
2025-05-15	ACELYRIN, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−10.3K sh	$2.17	−$22.3K	681,307
2025-05-15	ACELYRIN, Inc.A Award	Director, Chief Executive Officer	AAward	+30.9K sh	—	—	702,604
2025-05-15	ACELYRIN, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−11K sh	$2.17	−$24K	691,565
2025-03-17	ACELYRIN, Inc.S Sale	Director, Chief Executive Officer	SSale	−18K sh	$2.74	−$49.4K	671,753
2025-01-23	ACELYRIN, Inc.A Award	Director, Chief Executive Officer	AAward	+575K sh	—	—	689,739
2024-05-26	ACELYRIN, Inc.Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.2M sh	—	—	1,195,856
2024-05-15	ACELYRIN, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−10.2K sh	$4.47	−$45.7K	110,739
2024-01-09	ACELYRIN, Inc.Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+190K sh	—	—	190,114
2023-08-16	ACELYRIN, Inc.A Award	Director, Chief Executive Officer	AAward	+115K sh	—	—	119,676
2023-05-09	ACELYRIN, Inc.Employee Stock Option (right to buy)J Other	Director, Chief Executive Officer	JOther	+363K sh	—	—	362,719
2023-05-09	ACELYRIN, Inc.Employee Stock Option (right to buy)J Other	Director, Chief Executive Officer	JOther	+85.2K sh	—	—	85,226
2023-05-09	ACELYRIN, Inc.Employee Stock Option (right to buy)J Other	Director, Chief Executive Officer	JOther	−85.2K sh	—	—	0
2023-05-09	ACELYRIN, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$18.00	+$90K	5,000
2023-05-09	ACELYRIN, Inc.Employee Stock Option (right to buy)J Other	Director, Chief Executive Officer	JOther	−363K sh	—	—	0
2023-05-04	ACELYRIN, Inc.Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+85.2K sh	—	—	85,226
2022-09-02	Zymergen Inc.S Sale	Chief Legal Officer	SSale	−3,410 sh	$2.21	−$7,536.1	298,427
2022-08-02	Zymergen Inc.S Sale	Chief Legal Officer	SSale	−3,094 sh	$2.61	−$8,083.075	301,837
2022-07-05	Zymergen Inc.S Sale	Chief Legal Officer	SSale	−2,924 sh	$1.32	−$3,866.405	304,931
2022-06-02	Zymergen Inc.S Sale	Chief Legal Officer	SSale	−2,939 sh	$1.68	−$4,930.466	307,855
2022-05-02	Zymergen Inc.S Sale	Chief Legal Officer	SSale	−3,206 sh	$1.79	−$5,739.702	310,794
2022-03-11	Zymergen Inc.A Award	Chief Legal Officer	AAward	+217K sh	—	—	314,000
2021-10-26	Zymergen Inc.A Award	Chief Legal Officer	AAward	+97K sh	—	—	97,000
2021-10-26	Zymergen Inc.Stock OptionsA Award	Chief Legal Officer	AAward	+194K sh	—	—	194,000
2019-04-09	ATRAAtara Biotherapeutics, Inc.F Tax Payment	Senior VP & General Counsel	FTax Payment	−3,674 sh	$36.85	−$135K	66,389
2019-03-26	ATRAAtara Biotherapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+10K sh	—	—	70,063
2019-02-06	ATRAAtara Biotherapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+17.1K sh	—	—	60,063
2019-02-06	ATRAAtara Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Senior VP & General Counsel	AAward	+34.1K sh	—	—	34,125
2018-04-09	ATRAAtara Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Senior VP & General Counsel	AAward	+70K sh	—	—	70,000
2018-04-09	ATRAAtara Biotherapeutics, Inc.A Award	Senior VP & General Counsel	AAward	+42.5K sh	—	—	42,500
2017-03-15	RUNSunrun Inc.A Award	General Counsel	AAward	+131K sh	—	—	327,606
2017-03-15	RUNSunrun Inc. · Employee Stock Option (right to buy)A Award	General Counsel	AAward	+316K sh	—	—	316,000
2016-11-08	RUNSunrun Inc.A Award	General Counsel	AAward	+87.1K sh	—	—	196,606

Recent filings

Accepted (ET)
May 234
Kim Mina0001962918-25-000068
SEC(opens sec.gov)
May 194
Kim Mina0001962918-25-000038
SEC(opens sec.gov)
Mar 194
Kim Mina0001962918-25-000031
SEC(opens sec.gov)
Jan 244
Kim Mina0001962918-25-000007
SEC(opens sec.gov)
May 284
Kim Mina0001962918-24-000077
SEC(opens sec.gov)
May 174
Kim Mina0001962918-24-000061
SEC(opens sec.gov)
Jan 114
Kim Mina0001962918-24-000008
SEC(opens sec.gov)
Aug 184
Kim Mina0001962918-23-000023
SEC(opens sec.gov)
May 114
Kim Mina0001209191-23-028870
SEC(opens sec.gov)

Companies

Address

C/O ACELYRIN, INC. 4149 LIBERTY CANYON RD.

AGOURA HILLS, CA, 91301